We are proud to present the 6th episode of our successful All Things Urticaria Podcst Series
In this episode, Professors Marcus Maurer and Luis Felipe Ensina deliberate on the most recent findings that emerged at The American Academy of Allergy, Asthma & Immunology (AAAAI) conference held in San Antonio, Texas. In particular, Professor Maurer discusses poster presentations concerning the efficacious use of omalizumab and dupilumab for the management of urticaria. Professor Ensina expands the discussion by outlining ongoing projects and upcoming projects within UCARE that will be presented at the forthcoming UCARE conference in São Paulo in 2023.
Do you have suggestions for future episodes? Please reach out to us via email or fill out this form here and offer your suggestions for future topics and expert selection!
Read more news regarding urticaria
Journal Club,News
May 26, 2023Dear all, coming Thursday, the UCARE Journal Club will be held by Ceyda Çaytemel from Cam Sakura UCARE Center on: Çaytemel C, Türkoğlu Z, Ağırgöl Ş, Ustaoğlu E, Demir FT, [...]
News
May 19, 2023Dr. Marcus Maurer recently visited Seoul (South Korea) to attend the KAAACI International Congress, where he spoke at the Novartis Korea Luncheon symposium on "Advances in CSU Treatment Optimization: Yesterday, [...]
News
May 19, 2023We are happy to have gained Seoul National University Hospital in South Korea for the UCARE network. Please see some impressions of the audit below.
